nodes	percent_of_prediction	percent_of_DWPC	metapath
Niflumic Acid—Leflunomide—systemic lupus erythematosus	0.6	1	CrCtD
Niflumic Acid—PLA2G1B—Betamethasone—systemic lupus erythematosus	0.105	0.394	CbGbCtD
Niflumic Acid—PTGS2—systemic lupus erythematosus	0.0943	1	CbGaD
Niflumic Acid—PLA2G1B—Dexamethasone—systemic lupus erythematosus	0.061	0.229	CbGbCtD
Niflumic Acid—UGT1A9—Mycophenolate mofetil—systemic lupus erythematosus	0.0258	0.0967	CbGbCtD
Niflumic Acid—SLC16A1—Methotrexate—systemic lupus erythematosus	0.018	0.0675	CbGbCtD
Niflumic Acid—PTGS2—Dapsone—systemic lupus erythematosus	0.0146	0.0549	CbGbCtD
Niflumic Acid—PTGS2—Triamcinolone—systemic lupus erythematosus	0.0127	0.0476	CbGbCtD
Niflumic Acid—PTGS1—Dapsone—systemic lupus erythematosus	0.0123	0.0463	CbGbCtD
Niflumic Acid—PTGS2—Betamethasone—systemic lupus erythematosus	0.0109	0.0408	CbGbCtD
Niflumic Acid—PTGS2—Dexamethasone—systemic lupus erythematosus	0.00632	0.0237	CbGbCtD
Niflumic Acid—CLCNKA—nephron tubule—systemic lupus erythematosus	0.0022	0.0988	CbGeAlD
Niflumic Acid—CLCNKA—kidney—systemic lupus erythematosus	0.00194	0.0868	CbGeAlD
Niflumic Acid—PLA2G1B—blood plasma—systemic lupus erythematosus	0.00169	0.0757	CbGeAlD
Niflumic Acid—PLA2G4A—blood plasma—systemic lupus erythematosus	0.00103	0.0461	CbGeAlD
Niflumic Acid—PLA2G1B—connective tissue—systemic lupus erythematosus	0.000899	0.0403	CbGeAlD
Niflumic Acid—PLA2G1B—kidney—systemic lupus erythematosus	0.000766	0.0343	CbGeAlD
Niflumic Acid—SLC16A7—nephron tubule—systemic lupus erythematosus	0.000734	0.0329	CbGeAlD
Niflumic Acid—UGT1A9—kidney—systemic lupus erythematosus	0.0007	0.0314	CbGeAlD
Niflumic Acid—SLC16A7—cortex of kidney—systemic lupus erythematosus	0.000628	0.0282	CbGeAlD
Niflumic Acid—PLA2G4A—connective tissue—systemic lupus erythematosus	0.000548	0.0245	CbGeAlD
Niflumic Acid—PLA2G1B—lung—systemic lupus erythematosus	0.000542	0.0243	CbGeAlD
Niflumic Acid—SLC16A7—tendon—systemic lupus erythematosus	0.000521	0.0233	CbGeAlD
Niflumic Acid—PLA2G1B—nervous system—systemic lupus erythematosus	0.000502	0.0225	CbGeAlD
Niflumic Acid—PLA2G1B—central nervous system—systemic lupus erythematosus	0.000484	0.0217	CbGeAlD
Niflumic Acid—PTGS1—endothelium—systemic lupus erythematosus	0.000457	0.0205	CbGeAlD
Niflumic Acid—SLC16A7—lung—systemic lupus erythematosus	0.000457	0.0205	CbGeAlD
Niflumic Acid—PLA2G4A—cortex of kidney—systemic lupus erythematosus	0.000454	0.0204	CbGeAlD
Niflumic Acid—PTGS2—endothelium—systemic lupus erythematosus	0.000437	0.0196	CbGeAlD
Niflumic Acid—SLC16A7—nervous system—systemic lupus erythematosus	0.000423	0.019	CbGeAlD
Niflumic Acid—SLC16A1—kidney—systemic lupus erythematosus	0.000411	0.0184	CbGeAlD
Niflumic Acid—SLC16A7—central nervous system—systemic lupus erythematosus	0.000407	0.0183	CbGeAlD
Niflumic Acid—PTGS1—blood plasma—systemic lupus erythematosus	0.000406	0.0182	CbGeAlD
Niflumic Acid—PLA2G4A—Raltitrexed—Methotrexate—systemic lupus erythematosus	0.000405	0.266	CbGdCrCtD
Niflumic Acid—PTGS2—blood plasma—systemic lupus erythematosus	0.000388	0.0174	CbGeAlD
Niflumic Acid—PLA2G4A—tendon—systemic lupus erythematosus	0.000376	0.0169	CbGeAlD
Niflumic Acid—PLA2G4A—bone marrow—systemic lupus erythematosus	0.000365	0.0163	CbGeAlD
Niflumic Acid—SLC16A1—tendon—systemic lupus erythematosus	0.000331	0.0149	CbGeAlD
Niflumic Acid—PLA2G4A—lung—systemic lupus erythematosus	0.00033	0.0148	CbGeAlD
Niflumic Acid—PLA2G4A—nervous system—systemic lupus erythematosus	0.000306	0.0137	CbGeAlD
Niflumic Acid—PLA2G4A—central nervous system—systemic lupus erythematosus	0.000295	0.0132	CbGeAlD
Niflumic Acid—SLC16A1—lung—systemic lupus erythematosus	0.000291	0.013	CbGeAlD
Niflumic Acid—Floctafenine—PTGS2—systemic lupus erythematosus	0.000286	0.719	CrCbGaD
Niflumic Acid—SLC16A1—nervous system—systemic lupus erythematosus	0.000269	0.0121	CbGeAlD
Niflumic Acid—SLC16A1—central nervous system—systemic lupus erythematosus	0.000259	0.0116	CbGeAlD
Niflumic Acid—PTGS1—connective tissue—systemic lupus erythematosus	0.000216	0.00969	CbGeAlD
Niflumic Acid—PTGS2—connective tissue—systemic lupus erythematosus	0.000207	0.00927	CbGeAlD
Niflumic Acid—PTGS1—skin of body—systemic lupus erythematosus	0.000195	0.00875	CbGeAlD
Niflumic Acid—PTGS2—skin of body—systemic lupus erythematosus	0.000187	0.00837	CbGeAlD
Niflumic Acid—PTGS1—kidney—systemic lupus erythematosus	0.000184	0.00825	CbGeAlD
Niflumic Acid—PTGS2—kidney—systemic lupus erythematosus	0.000176	0.00789	CbGeAlD
Niflumic Acid—PTGS2—lymphoid tissue—systemic lupus erythematosus	0.000151	0.00678	CbGeAlD
Niflumic Acid—PTGS1—tendon—systemic lupus erythematosus	0.000149	0.00666	CbGeAlD
Niflumic Acid—PTGS2—tendon—systemic lupus erythematosus	0.000142	0.00637	CbGeAlD
Niflumic Acid—PTGS2—bone marrow—systemic lupus erythematosus	0.000138	0.00617	CbGeAlD
Niflumic Acid—PTGS1—lung—systemic lupus erythematosus	0.00013	0.00585	CbGeAlD
Niflumic Acid—PTGS2—lung—systemic lupus erythematosus	0.000125	0.00559	CbGeAlD
Niflumic Acid—PTGS1—nervous system—systemic lupus erythematosus	0.000121	0.00542	CbGeAlD
Niflumic Acid—PTGS1—central nervous system—systemic lupus erythematosus	0.000116	0.00521	CbGeAlD
Niflumic Acid—PTGS2—nervous system—systemic lupus erythematosus	0.000115	0.00518	CbGeAlD
Niflumic Acid—PTGS2—Fluocinonide—Methylprednisolone—systemic lupus erythematosus	0.000112	0.0737	CbGdCrCtD
Niflumic Acid—Mefenamic acid—PTGS2—systemic lupus erythematosus	0.000112	0.281	CrCbGaD
Niflumic Acid—PTGS2—central nervous system—systemic lupus erythematosus	0.000111	0.00498	CbGeAlD
Niflumic Acid—PTGS2—Fluocinonide—Dexamethasone—systemic lupus erythematosus	0.00011	0.0725	CbGdCrCtD
Niflumic Acid—PTGS2—Fluocinonide—Betamethasone—systemic lupus erythematosus	0.00011	0.0725	CbGdCrCtD
Niflumic Acid—PTGS2—Fluocinonide—Triamcinolone—systemic lupus erythematosus	0.000108	0.0708	CbGdCrCtD
Niflumic Acid—PTGS2—Fluticasone Propionate—Methylprednisolone—systemic lupus erythematosus	6.77e-05	0.0444	CbGdCrCtD
Niflumic Acid—PTGS2—Fluticasone Propionate—Betamethasone—systemic lupus erythematosus	6.66e-05	0.0437	CbGdCrCtD
Niflumic Acid—PTGS2—Fluticasone Propionate—Dexamethasone—systemic lupus erythematosus	6.66e-05	0.0437	CbGdCrCtD
Niflumic Acid—PTGS2—Fluticasone Propionate—Triamcinolone—systemic lupus erythematosus	6.51e-05	0.0427	CbGdCrCtD
Niflumic Acid—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EP300—systemic lupus erythematosus	3.98e-05	0.0027	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—CLU—systemic lupus erythematosus	3.91e-05	0.00266	CbGpPWpGaD
Niflumic Acid—UGT1A9—NRF2 pathway—RXRA—systemic lupus erythematosus	3.82e-05	0.00259	CbGpPWpGaD
Niflumic Acid—PLA2G4A—AGE/RAGE pathway—MMP9—systemic lupus erythematosus	3.79e-05	0.00257	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—P2RY12—systemic lupus erythematosus	3.79e-05	0.00257	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Dexamethasone—Hydrocortisone—systemic lupus erythematosus	3.75e-05	0.0246	CbGdCrCtD
Niflumic Acid—PLA2G4A—Betamethasone—Hydrocortisone—systemic lupus erythematosus	3.75e-05	0.0246	CbGdCrCtD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	3.72e-05	0.00252	CbGpPWpGaD
Niflumic Acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—systemic lupus erythematosus	3.68e-05	0.0025	CbGpPWpGaD
Niflumic Acid—PTGS1—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	3.64e-05	0.00247	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Platelet activation, signaling and aggregation—RASGRP1—systemic lupus erythematosus	3.59e-05	0.00244	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—GADD45A—systemic lupus erythematosus	3.55e-05	0.00241	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Dexamethasone—Methylprednisolone—systemic lupus erythematosus	3.54e-05	0.0232	CbGdCrCtD
Niflumic Acid—PLA2G4A—Betamethasone—Methylprednisolone—systemic lupus erythematosus	3.54e-05	0.0232	CbGdCrCtD
Niflumic Acid—SLC16A1—Hemostasis—SELE—systemic lupus erythematosus	3.49e-05	0.00237	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—CSK—systemic lupus erythematosus	3.49e-05	0.00237	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Betamethasone—Dexamethasone—systemic lupus erythematosus	3.48e-05	0.0229	CbGdCrCtD
Niflumic Acid—PLA2G4A—Dexamethasone—Betamethasone—systemic lupus erythematosus	3.48e-05	0.0229	CbGdCrCtD
Niflumic Acid—PTGS1—Selenium Micronutrient Network—CRP—systemic lupus erythematosus	3.46e-05	0.00235	CbGpPWpGaD
Niflumic Acid—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic lupus erythematosus	3.46e-05	0.00235	CbGpPWpGaD
Niflumic Acid—PTGS2—Overview of nanoparticle effects—IL6—systemic lupus erythematosus	3.42e-05	0.00232	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—ITGAX—systemic lupus erythematosus	3.41e-05	0.00232	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	3.41e-05	0.00232	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Betamethasone—Triamcinolone—systemic lupus erythematosus	3.4e-05	0.0223	CbGdCrCtD
Niflumic Acid—PLA2G4A—Dexamethasone—Triamcinolone—systemic lupus erythematosus	3.4e-05	0.0223	CbGdCrCtD
Niflumic Acid—PLA2G4A—Hemostasis—F3—systemic lupus erythematosus	3.36e-05	0.00228	CbGpPWpGaD
Niflumic Acid—UGT1A9—Biological oxidations—RXRA—systemic lupus erythematosus	3.35e-05	0.00227	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—ITGAM—systemic lupus erythematosus	3.28e-05	0.00223	CbGpPWpGaD
Niflumic Acid—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—RXRA—systemic lupus erythematosus	3.23e-05	0.00219	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Dexamethasone—Prednisone—systemic lupus erythematosus	3.23e-05	0.0212	CbGdCrCtD
Niflumic Acid—PLA2G4A—Betamethasone—Prednisone—systemic lupus erythematosus	3.23e-05	0.0212	CbGdCrCtD
Niflumic Acid—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—systemic lupus erythematosus	3.23e-05	0.00219	CbGpPWpGaD
Niflumic Acid—PTGS1—Selenium Micronutrient Network—F2—systemic lupus erythematosus	3.19e-05	0.00217	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—LYN—systemic lupus erythematosus	3.17e-05	0.00215	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Dexamethasone—Prednisolone—systemic lupus erythematosus	3.15e-05	0.0207	CbGdCrCtD
Niflumic Acid—PLA2G4A—Betamethasone—Prednisolone—systemic lupus erythematosus	3.15e-05	0.0207	CbGdCrCtD
Niflumic Acid—SLC16A1—Hemostasis—SH2B3—systemic lupus erythematosus	3.11e-05	0.00211	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	3.05e-05	0.00207	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—CLU—systemic lupus erythematosus	3.04e-05	0.00207	CbGpPWpGaD
Niflumic Acid—UGT1A9—PPARA activates gene expression—PPARG—systemic lupus erythematosus	3.02e-05	0.00205	CbGpPWpGaD
Niflumic Acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—systemic lupus erythematosus	3.02e-05	0.00205	CbGpPWpGaD
Niflumic Acid—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—systemic lupus erythematosus	2.96e-05	0.00201	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—P2RY12—systemic lupus erythematosus	2.95e-05	0.002	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	2.94e-05	0.00199	CbGpPWpGaD
Niflumic Acid—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—systemic lupus erythematosus	2.93e-05	0.00199	CbGpPWpGaD
Niflumic Acid—PTGS1—Selenium Micronutrient Network—CCL2—systemic lupus erythematosus	2.84e-05	0.00193	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Platelet activation, signaling and aggregation—JAK1—systemic lupus erythematosus	2.78e-05	0.00189	CbGpPWpGaD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—CRP—systemic lupus erythematosus	2.75e-05	0.00186	CbGpPWpGaD
Niflumic Acid—PTGS1—Biological oxidations—RXRA—systemic lupus erythematosus	2.73e-05	0.00185	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—SELE—systemic lupus erythematosus	2.71e-05	0.00184	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—CSK—systemic lupus erythematosus	2.71e-05	0.00184	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—NAT2—systemic lupus erythematosus	2.71e-05	0.00184	CbGpPWpGaD
Niflumic Acid—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—systemic lupus erythematosus	2.7e-05	0.00184	CbGpPWpGaD
Niflumic Acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—systemic lupus erythematosus	2.68e-05	0.00182	CbGpPWpGaD
Niflumic Acid—PTGS1—Selenium Micronutrient Network—ALB—systemic lupus erythematosus	2.65e-05	0.0018	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Platelet activation, signaling and aggregation—IL2RA—systemic lupus erythematosus	2.6e-05	0.00176	CbGpPWpGaD
Niflumic Acid—PTGS2—Aryl Hydrocarbon Receptor—EP300—systemic lupus erythematosus	2.57e-05	0.00175	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—ITGAM—systemic lupus erythematosus	2.55e-05	0.00173	CbGpPWpGaD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—F2—systemic lupus erythematosus	2.53e-05	0.00172	CbGpPWpGaD
Niflumic Acid—SLC16A7—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	2.52e-05	0.00171	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—IL4—systemic lupus erythematosus	2.51e-05	0.00171	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—LYN—systemic lupus erythematosus	2.46e-05	0.00167	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—IFNA1—systemic lupus erythematosus	2.44e-05	0.00166	CbGpPWpGaD
Niflumic Acid—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—systemic lupus erythematosus	2.44e-05	0.00165	CbGpPWpGaD
Niflumic Acid—PTGS1—Selenium Micronutrient Network—IFNG—systemic lupus erythematosus	2.42e-05	0.00164	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—SH2B3—systemic lupus erythematosus	2.42e-05	0.00164	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	2.41e-05	0.00164	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—RASGRP1—systemic lupus erythematosus	2.38e-05	0.00161	CbGpPWpGaD
Niflumic Acid—PTGS1—Selenium Micronutrient Network—PTGS2—systemic lupus erythematosus	2.32e-05	0.00157	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	2.28e-05	0.00154	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Platelet activation, signaling and aggregation—F2—systemic lupus erythematosus	2.26e-05	0.00154	CbGpPWpGaD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—CCL2—systemic lupus erythematosus	2.26e-05	0.00153	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	2.15e-05	0.00146	CbGpPWpGaD
Niflumic Acid—SLC16A1—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	2.12e-05	0.00144	CbGpPWpGaD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—ALB—systemic lupus erythematosus	2.1e-05	0.00143	CbGpPWpGaD
Niflumic Acid—PTGS2—Aryl Hydrocarbon Receptor—TNF—systemic lupus erythematosus	2.09e-05	0.00142	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—TLR4—systemic lupus erythematosus	2.08e-05	0.00141	CbGpPWpGaD
Niflumic Acid—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—systemic lupus erythematosus	2.04e-05	0.00139	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	1.99e-05	0.00135	CbGpPWpGaD
Niflumic Acid—UGT1A9—PPARA activates gene expression—EP300—systemic lupus erythematosus	1.98e-05	0.00134	CbGpPWpGaD
Niflumic Acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—systemic lupus erythematosus	1.95e-05	0.00133	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.94e-05	0.00132	CbGpPWpGaD
Niflumic Acid—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—systemic lupus erythematosus	1.94e-05	0.00132	CbGpPWpGaD
Niflumic Acid—PTGS2—C-MYB transcription factor network—CD4—systemic lupus erythematosus	1.92e-05	0.00131	CbGpPWpGaD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—IFNG—systemic lupus erythematosus	1.92e-05	0.0013	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—IFNA1—systemic lupus erythematosus	1.9e-05	0.00129	CbGpPWpGaD
Niflumic Acid—SLC16A1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	1.9e-05	0.00129	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Platelet activation, signaling and aggregation—ALB—systemic lupus erythematosus	1.88e-05	0.00128	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—RASGRP1—systemic lupus erythematosus	1.85e-05	0.00126	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	1.85e-05	0.00125	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—JAK1—systemic lupus erythematosus	1.84e-05	0.00125	CbGpPWpGaD
Niflumic Acid—PTGS2—C-MYB transcription factor network—CDKN1B—systemic lupus erythematosus	1.81e-05	0.00123	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—CCL2—systemic lupus erythematosus	1.79e-05	0.00121	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	1.75e-05	0.00119	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—IL2RA—systemic lupus erythematosus	1.72e-05	0.00117	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.69e-05	0.00115	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—P2RY12—systemic lupus erythematosus	1.69e-05	0.00115	CbGpPWpGaD
Niflumic Acid—PTGS2—C-MYB transcription factor network—CDKN1A—systemic lupus erythematosus	1.67e-05	0.00113	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	1.63e-05	0.00111	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	1.61e-05	0.0011	CbGpPWpGaD
Niflumic Acid—PTGS2—C-MYB transcription factor network—EP300—systemic lupus erythematosus	1.59e-05	0.00108	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—NAT2—systemic lupus erythematosus	1.59e-05	0.00108	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	1.57e-05	0.00107	CbGpPWpGaD
Niflumic Acid—PTGS1—Selenium Micronutrient Network—TNF—systemic lupus erythematosus	1.57e-05	0.00106	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.55e-05	0.00105	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	1.54e-05	0.00104	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Platelet activation, signaling and aggregation—IL2—systemic lupus erythematosus	1.52e-05	0.00103	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—RXRA—systemic lupus erythematosus	1.52e-05	0.00103	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—IFNG—systemic lupus erythematosus	1.52e-05	0.00103	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—F2—systemic lupus erythematosus	1.5e-05	0.00102	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	1.45e-05	0.000988	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—JAK1—systemic lupus erythematosus	1.43e-05	0.000974	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.41e-05	0.000957	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—CDKN1B—systemic lupus erythematosus	1.38e-05	0.000936	CbGpPWpGaD
Niflumic Acid—UGT1A9—NRF2 pathway—TGFB1—systemic lupus erythematosus	1.37e-05	0.000931	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—IL2—systemic lupus erythematosus	1.35e-05	0.000916	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—IL2RA—systemic lupus erythematosus	1.34e-05	0.000909	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	1.34e-05	0.000907	CbGpPWpGaD
Niflumic Acid—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—systemic lupus erythematosus	1.33e-05	0.000906	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—systemic lupus erythematosus	1.29e-05	0.000879	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.29e-05	0.000874	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—MMP9—systemic lupus erythematosus	1.28e-05	0.000867	CbGpPWpGaD
Niflumic Acid—PTGS1—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	1.26e-05	0.000858	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	1.25e-05	0.000847	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—ALB—systemic lupus erythematosus	1.25e-05	0.000845	CbGpPWpGaD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—TNF—systemic lupus erythematosus	1.24e-05	0.000844	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—NAT2—systemic lupus erythematosus	1.23e-05	0.000838	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—NOS3—systemic lupus erythematosus	1.19e-05	0.000809	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Platelet activation, signaling and aggregation—TGFB1—systemic lupus erythematosus	1.19e-05	0.000807	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—F2—systemic lupus erythematosus	1.17e-05	0.000792	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—CXCL12—systemic lupus erythematosus	1.14e-05	0.000773	CbGpPWpGaD
Niflumic Acid—SLC16A1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	1.08e-05	0.000732	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	1.06e-05	0.000721	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—TGFB1—systemic lupus erythematosus	1.05e-05	0.000715	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.05e-05	0.000712	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—TLR9—systemic lupus erythematosus	1.03e-05	0.0007	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—NAT2—systemic lupus erythematosus	1.02e-05	0.000694	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—IL2—systemic lupus erythematosus	1.01e-05	0.000686	CbGpPWpGaD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	1e-05	0.000681	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—P2RY12—systemic lupus erythematosus	9.99e-06	0.000678	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—TNF—systemic lupus erythematosus	9.83e-06	0.000667	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	9.8e-06	0.000666	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—XRCC6—systemic lupus erythematosus	9.8e-06	0.000665	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—ALB—systemic lupus erythematosus	9.68e-06	0.000657	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—PPARG—systemic lupus erythematosus	9.59e-06	0.000651	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	9.43e-06	0.000641	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	9.38e-06	0.000637	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—NOS3—systemic lupus erythematosus	9.26e-06	0.000629	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CSK—systemic lupus erythematosus	9.19e-06	0.000624	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—EP300—systemic lupus erythematosus	9.06e-06	0.000615	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—RXRA—systemic lupus erythematosus	8.89e-06	0.000604	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	8.81e-06	0.000599	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	8.66e-06	0.000588	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—ALB—systemic lupus erythematosus	8.63e-06	0.000586	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—VEGFA—systemic lupus erythematosus	8.58e-06	0.000583	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—NCF2—systemic lupus erythematosus	8.41e-06	0.000571	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—LYN—systemic lupus erythematosus	8.35e-06	0.000567	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—NAT2—systemic lupus erythematosus	8.33e-06	0.000566	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	8.33e-06	0.000565	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—NOS3—systemic lupus erythematosus	8.25e-06	0.00056	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	8.24e-06	0.000559	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—JAK1—systemic lupus erythematosus	8.23e-06	0.000559	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—SH2B3—systemic lupus erythematosus	8.19e-06	0.000556	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	8.12e-06	0.000552	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—IL6—systemic lupus erythematosus	7.93e-06	0.000539	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—TGFB1—systemic lupus erythematosus	7.88e-06	0.000535	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—IL2—systemic lupus erythematosus	7.85e-06	0.000533	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	7.8e-06	0.00053	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—CCR5—systemic lupus erythematosus	7.8e-06	0.00053	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	7.71e-06	0.000524	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—IL2RA—systemic lupus erythematosus	7.69e-06	0.000522	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—C3—systemic lupus erythematosus	7.62e-06	0.000517	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—PTGS2—systemic lupus erythematosus	7.55e-06	0.000512	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	7.3e-06	0.000496	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—HIST2H2AC—systemic lupus erythematosus	7.22e-06	0.00049	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	7.16e-06	0.000486	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—EP300—systemic lupus erythematosus	7.05e-06	0.000478	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—CSK—systemic lupus erythematosus	7.04e-06	0.000478	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—RXRA—systemic lupus erythematosus	6.91e-06	0.00047	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CXCL12—systemic lupus erythematosus	6.72e-06	0.000456	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—F2—systemic lupus erythematosus	6.69e-06	0.000454	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	6.69e-06	0.000454	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—VEGFA—systemic lupus erythematosus	6.67e-06	0.000453	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	6.62e-06	0.00045	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—CD247—systemic lupus erythematosus	6.62e-06	0.000449	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—NAT2—systemic lupus erythematosus	6.61e-06	0.000449	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—JUNB—systemic lupus erythematosus	6.6e-06	0.000448	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—NCF2—systemic lupus erythematosus	6.44e-06	0.000437	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	6.41e-06	0.000436	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	6.39e-06	0.000434	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—EP300—systemic lupus erythematosus	6.28e-06	0.000426	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—RASGRP1—systemic lupus erythematosus	6.27e-06	0.000426	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—TGFB1—systemic lupus erythematosus	6.12e-06	0.000416	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PRL—systemic lupus erythematosus	6.08e-06	0.000413	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—CCL2—systemic lupus erythematosus	5.96e-06	0.000405	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	5.95e-06	0.000404	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—RXRA—systemic lupus erythematosus	5.73e-06	0.000389	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—PPARG—systemic lupus erythematosus	5.61e-06	0.000381	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—TYK2—systemic lupus erythematosus	5.42e-06	0.000368	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	5.31e-06	0.000361	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	5.26e-06	0.000357	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	5.21e-06	0.000354	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—JUNB—systemic lupus erythematosus	5.05e-06	0.000343	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—ALB—systemic lupus erythematosus	5.05e-06	0.000343	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—JAK1—systemic lupus erythematosus	4.86e-06	0.00033	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—NOS3—systemic lupus erythematosus	4.83e-06	0.000328	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	4.73e-06	0.000321	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—RXRA—systemic lupus erythematosus	4.67e-06	0.000317	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—PRL—systemic lupus erythematosus	4.65e-06	0.000316	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CCR5—systemic lupus erythematosus	4.61e-06	0.000313	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IL2RA—systemic lupus erythematosus	4.54e-06	0.000308	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—IL2—systemic lupus erythematosus	4.51e-06	0.000306	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—C3—systemic lupus erythematosus	4.5e-06	0.000306	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—PTGS2—systemic lupus erythematosus	4.42e-06	0.0003	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—PPARG—systemic lupus erythematosus	4.37e-06	0.000296	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	4.33e-06	0.000294	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—F2—systemic lupus erythematosus	3.95e-06	0.000268	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—ALB—systemic lupus erythematosus	3.93e-06	0.000267	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CD80—systemic lupus erythematosus	3.79e-06	0.000257	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—NOS3—systemic lupus erythematosus	3.76e-06	0.000255	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—JAK1—systemic lupus erythematosus	3.72e-06	0.000253	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—RXRA—systemic lupus erythematosus	3.71e-06	0.000252	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—EP300—systemic lupus erythematosus	3.67e-06	0.000249	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PPARG—systemic lupus erythematosus	3.62e-06	0.000246	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—CCR5—systemic lupus erythematosus	3.53e-06	0.00024	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CCL2—systemic lupus erythematosus	3.52e-06	0.000239	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	3.44e-06	0.000234	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—PTGS2—systemic lupus erythematosus	3.43e-06	0.000233	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—ALB—systemic lupus erythematosus	3.25e-06	0.000221	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—TYK2—systemic lupus erythematosus	3.2e-06	0.000217	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—NOS3—systemic lupus erythematosus	3.14e-06	0.000213	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—NOS3—systemic lupus erythematosus	3.11e-06	0.000211	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PPARG—systemic lupus erythematosus	2.95e-06	0.0002	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—CD80—systemic lupus erythematosus	2.9e-06	0.000197	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—EP300—systemic lupus erythematosus	2.86e-06	0.000194	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PTGS2—systemic lupus erythematosus	2.85e-06	0.000193	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.72e-06	0.000185	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IL2—systemic lupus erythematosus	2.66e-06	0.000181	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—ALB—systemic lupus erythematosus	2.65e-06	0.00018	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—IL6—systemic lupus erythematosus	2.65e-06	0.00018	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—NOS3—systemic lupus erythematosus	2.54e-06	0.000172	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—MMP9—systemic lupus erythematosus	2.52e-06	0.000171	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.51e-06	0.00017	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—TYK2—systemic lupus erythematosus	2.45e-06	0.000166	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—NOS3—systemic lupus erythematosus	2.4e-06	0.000163	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—EP300—systemic lupus erythematosus	2.39e-06	0.000162	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—EP300—systemic lupus erythematosus	2.37e-06	0.000161	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PPARG—systemic lupus erythematosus	2.34e-06	0.000159	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PTGS2—systemic lupus erythematosus	2.32e-06	0.000158	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.26e-06	0.000154	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—CD4—systemic lupus erythematosus	2.22e-06	0.00015	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—ALB—systemic lupus erythematosus	2.11e-06	0.000143	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—CDKN1B—systemic lupus erythematosus	2.08e-06	0.000141	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.08e-06	0.000141	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—NOS3—systemic lupus erythematosus	2.01e-06	0.000137	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—EP300—systemic lupus erythematosus	1.93e-06	0.000131	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—CDKN1A—systemic lupus erythematosus	1.92e-06	0.000131	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—EP300—systemic lupus erythematosus	1.83e-06	0.000124	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—TGFB1—systemic lupus erythematosus	1.59e-06	0.000108	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IL6—systemic lupus erythematosus	1.56e-06	0.000106	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—EP300—systemic lupus erythematosus	1.53e-06	0.000104	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—IL6—systemic lupus erythematosus	1.2e-06	8.13e-05	CbGpPWpGaD
